pargyline has been researched along with Anochlesia in 3 studies
Pargyline: A monoamine oxidase inhibitor with antihypertensive properties.
| Excerpt | Relevance | Reference |
|---|
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Voith, K | 1 |
| Worms, P | 1 |
| Kan, JP | 1 |
| Wermuth, CG | 1 |
| Roncucci, R | 1 |
| Bizière, K | 1 |
| Boissier, JR | 1 |
| Simon, P | 1 |
| Villeneuve, A | 1 |
| Larousse, C | 1 |
3 other studies available for pargyline and Anochlesia
| Article | Year |
|---|---|
Synthetic MIF analogues. Part II: Dopa potentiation and fluphenazine antagonism.
Topics: Animals; Behavior, Animal; Catalepsy; Dihydroxyphenylalanine; Drug Synergism; Fluphenazine; Humans; | 1977 |
SR 95191, a selective inhibitor of type A monoamine oxidase with dopaminergic properties. I. Psychopharmacological profile in rodents.
Topics: 5-Hydroxytryptophan; Amphetamines; Animals; Antidepressive Agents; Behavior, Animal; Benzamides; Bod | 1987 |
Flurothyl in mice: seizure, post-convulsive behavior, and interactions with psychotropic drugs.
Topics: Amphetamine; Animals; Atropine; Behavior, Animal; Biperiden; Caffeine; Catalepsy; Central Nervous Sy | 1968 |